Seres Therapeutics Files 2024 10-K
Ticker: MCRB · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | 10-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Seres Therapeutics filed its 2024 10-K, detailing financials and operations. Check for loan facility and stock plan updates.
AI Summary
Seres Therapeutics, Inc. filed its 2024 10-K on March 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Seres Health, Inc., is involved in pharmaceutical preparations. Key financial events and plans, including details on its term loan facility with Oaktree Fund Administration LLC and various stock incentive plans, are outlined in the filing.
Why It Matters
This filing provides a comprehensive overview of Seres Therapeutics' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — The company operates in the pharmaceutical sector, which is inherently high-risk due to R&D costs, regulatory hurdles, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-13 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Seres Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-13 (date) — Filing date
- Seres Health, Inc. (company) — Former company name
- Oaktree Fund Administration LLC (company) — Lender in term loan facility
- mcrb:TermLoanFacilityMember (dollar_amount) — Details of the term loan facility
FAQ
What is the primary business of Seres Therapeutics, Inc.?
Seres Therapeutics, Inc. is involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When did Seres Therapeutics, Inc. file its 10-K report?
Seres Therapeutics, Inc. filed its 10-K report on March 13, 2025.
What was the fiscal year end for this 10-K filing?
The fiscal year end for this 10-K filing was December 31, 2024.
What is the former name of Seres Therapeutics, Inc.?
The former name of Seres Therapeutics, Inc. was Seres Health, Inc., with a date of name change on June 3, 2014.
Are there any specific loan facilities mentioned in the filing data?
Yes, the filing data mentions a 'mcrb:TermLoanFacilityMember' in relation to 'mcrb:OaktreeFundAdministrationLlcMember' and specific tranches like 'mcrb:TrancheALoanMember' and 'mcrb:TrancheBWarrantMember' dated April 27, 2023.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Seres Therapeutics, Inc. (MCRB).